Livraghi L, Martella F, Ghilli M, Angiolini C, et al. Prospective study on Oncotype DX(R) assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial. Eur J Cancer 2024;213:115108.
PMID: 39522332